A unique proteolytic fragment of alpha1-antitrypsin is elevated in ductal fluid of breast cancer patient

Breast Cancer Research and Treatment

Volumn 123, Issue 1, 2010, Pages 73-86

  Zhou, Junma ^a   Trock, Bruce ^a   Tsangaris, Theodore N ^a   Friedman, Neil B ^b   Shapiro, Deanna ^a   Brotzman, Michelle ^a   Chan Li, Yee ^a   Chan, Daniel W ^a   Li, Jinong ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b Hoffberger Breast Center at Mercy Hospital   (United States)

Author keywords

Breast cancer biomarker; Nipple aspiration fluid; Proteolytic fragment of alpha1 antitrypsin

Indexed keywords

ALPHA 1 ANTITRYPSIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; LEUKOCYTE ELASTASE; MATRILYSIN; PROGESTERONE RECEPTOR; PEPTIDE FRAGMENT; TUMOR MARKER;

ADULT; ARTICLE; ASPIRATION BIOPSY; BREAST CANCER; BREAST DUCT; BREAST HYPERPLASIA; CANCER STAGING; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEGRADATION; FEMALE; GEL ELECTROPHORESIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN SYNTHESIS; SEQUENCE ANALYSIS; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TANDEM MASS SPECTROMETRY; TUMOR VOLUME; ADOLESCENT; AMINO ACID SEQUENCE; BREAST TUMOR; CHEMISTRY; HYPERPLASIA; MASS SPECTROMETRY; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; NIPPLE ASPIRATION; PATHOLOGY; PRECANCER; WESTERN BLOTTING; YOUNG ADULT;

ADOLESCENT; ADULT; ALPHA 1-ANTITRYPSIN; AMINO ACID SEQUENCE; BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; HYPERPLASIA; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM STAGING; NIPPLE ASPIRATE FLUID; PEPTIDE FRAGMENTS; PRECANCEROUS CONDITIONS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 77955772279     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0625-5     Document Type: Article

References (43)

1. ER Sauter E Ross M Daly,, et al. 1997 Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk Br J Cancer 76 494 501 1:STN:280:DyaK2svhvV2msw%3D%3D 9275027
2. R Hsiung W Zhu G Klein,, et al. 2002 High basic fibroblast growth factor levels in nipple aspirate fluid are correlated with breast cancer Cancer J 8 303 310 10.1097/00130404-200207000-00006 12184408
3. P Klein E Glaser L Grogan,, et al. 2001 Biomarker assays in nipple aspirate fluid Breast J 7 378 387 10.1046/j.1524-4741.2001.07601.x 1:CAS:528:DC%2BD38XmvFaksA%3D%3D 11843848 (Pubitemid 34024459)
4. J Li J Zhao X Yu,, et al. 2005 Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid Clin Cancer Res 11 8312 8320 10.1158/1078-0432.CCR-05-1538 1:CAS:528:DC%2BD2MXht1KjsrjE 16322290 (Pubitemid 41746942)
5. OW Sartorius HS Smith P Morris D Benedict L Friesen 1977 Cytologic evaluation of breast fluid in the detection of breast disease J Natl Cancer Inst 59 1073 1080 1:STN:280:DyaE1c%2FgvVSiug%3D%3D 903989
6. HM Kuerer IL Goldknopf H Fritsche S Krishnamurthy EA Sheta KK Hunt 2002 Identification of distinct protein expression patterns in bilateral matched pair breast ductal fluid specimens from women with unilateral invasive breast carcinoma. High-throughput biomarker discovery Cancer 95 2276 2282 10.1002/cncr.10974 1:CAS:528:DC%2BD38XpsFSitL4%3D 12436432 (Pubitemid 35351132)
7. TM Pawlik DH Hawke Y Liu,, et al. 2006 Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein BMC Cancer 6 68 10.1186/1471-2407-6-68 16542425
8. SM Varnum CC Covington RL Woodbury,, et al. 2003 Proteomic characterization of nipple aspirate fluid: identification of potential biomarkers of breast cancer Breast Cancer Res Treat 80 87 97 10.1023/A:1024479106887 1:CAS:528:DC%2BD3sXkvVCksbs%3D 12889602 (Pubitemid 36851288)
9. TM Pawlik H Fritsche KR Coombes,, et al. 2005 Significant differences in nipple aspirate fluid protein expression between healthy women and those with breast cancer demonstrated by time-of-flight mass spectrometry Breast Cancer Res Treat 89 149 157 10.1007/s10549-004-1710-4 1:CAS:528:DC%2BD2MXhtVamsr0%3D 15692757 (Pubitemid 40253557)
10. ER Sauter T Welch A Magklara G Klein EP Diamandis 2002 Ethnic variation in kallikrein expression in nipple aspirate fluid Int J Cancer 100 678 682 10.1002/ijc.10556 1:CAS:528:DC%2BD38XlvFKgsr4%3D 12209605 (Pubitemid 34832977)
11. CP Paweletz B Trock M Pennanen,, et al. 2001 Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer Dis Markers 17 301 307 1:CAS:528: DC%2BD38Xht1yksLc%3D 11790897
12. ER Sauter W Zhu XJ Fan RP Wassell I Chervoneva GC Du Bois 2002 Proteomic analysis of nipple aspirate fluid to detect biologic markers of breast cancer Br J Cancer 86 1440 1443 10.1038/sj.bjc.6600285 1:CAS:528:DC%2BD38XkvVKjsb4%3D 11986778 (Pubitemid 34548067)
13. NL Petrakis 1986 Physiologic, biochemical, and cytologic aspects of nipple aspirate fluid Breast Cancer Res Treat 8 7 19 10.1007/BF01805919 1:CAS:528:DyaL2sXkslylug%3D%3D 3539239 (Pubitemid 17186658)
14. NL Petrakis 1993 Nipple aspirate fluid in epidemiologic studies of breast disease Epidemiol Rev 15 188 195 1:STN:280:DyaK2c%2FgvFCjtw%3D%3D 8405203
15. M Wrensch NL Petrakis EB King MM Lee R Miike 1993 Breast cancer risk associated with abnormal cytology in nipple aspirates of breast fluid and prior history of breast biopsy Am J Epidemiol 137 829 833 1:STN:280: DyaK3s3kvVyqtA%3D%3D 8484374
16. CS Jorgensen M Jagd BK Sorensen,, et al. 2004 Efficacy and compatibility with mass spectrometry of methods for elution of proteins from sodium dodecyl sulfate-polyacrylamide gels and polyvinyldifluoride membranes Anal Biochem 330 87 97 10.1016/j.ab.2004.03.012 1:CAS:528:DC%2BD2cXkslSjsLk%3D 15183766 (Pubitemid 38746979)
17. A Graham K Hayes S Weidinger CR Newton AF Markham NA Kalsheker 1990 Characterisation of the alpha-1-antitrypsin M3 gene, a normal variant Hum Genet 85 381 382 1:STN:280:DyaK3czmvVSqtQ%3D%3D 2394452
18. PE Desrochers JJ Jeffrey SJ Weiss 1991 Interstitial collagenase (matrix metalloproteinase-1) expresses serpinase activity J Clin Invest 87 2258 2265 10.1172/JCI115262 1:CAS:528:DyaK38XhslKguw%3D%3D 1645757
19. W Li AY Savinov DV Rozanov,, et al. 2004 Matrix metalloproteinase-26 is associated with estrogen-dependent malignancies and targets alpha1-antitrypsin serpin Cancer Res 64 8657 8665 10.1158/0008-5472.CAN-04-3019 1:CAS:528:DC%2BD2cXhtVCjs7rM 15574774 (Pubitemid 39552080)
20. D Pei G Majmudar SJ Weiss 1994 Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3 J Biol Chem 269 25849 25855 1:CAS:528:DyaK2cXlvF2htL8%3D 7523394
21. UI Sires G Murphy VM Baragi CJ Fliszar HG Welgus RM Senior 1994 Matrilysin is much more efficient than other matrix metalloproteinases in the proteolytic inactivation of alpha 1-antitrypsin Biochem Biophys Res Commun 204 613 620 10.1006/bbrc.1994.2503 1:CAS:528:DyaK2MXhsVeju7w%3D 7980522 (Pubitemid 24343964)
22. PG Winyard Z Zhang K Chidwick DR Blake RW Carrell G Murphy 1991 Proteolytic inactivation of human alpha 1 antitrypsin by human stromelysin FEBS Lett 279 91 94 10.1016/0014-5793(91)80258-5 1:CAS:528:DyaK3MXhvVWisrs%3D 1995350
23. Z Zhang PG Winyard K Chidwick,, et al. 1994 Proteolysis of human native and oxidised alpha 1-proteinase inhibitor by matrilysin and stromelysin Biochim Biophys Acta 1199 224 228 1:CAS:528:DyaK2cXkt12lu7Y%3D 8123672
24. S Krishnamurthy HM Kuerer 2002 Foam cells in nipple aspiration fluid Cytopathology 13 64 10.1046/j.1365-2303.2002.0362a.x 1:STN:280: DC%2BD383lvVOgsQ%3D%3D 11985570
25. EP Molmenti DH Perlmutter DC Rubin 1993 Cell-specific expression of alpha 1-antitrypsin in human intestinal epithelium J Clin Invest 92 2022 2034 10.1172/JCI116797 1:CAS:528:DyaK2cXlsVyi 8408656
26. H Kataoka K Nabeshima N Komada M Koono 1989 New human colorectal carcinoma cell lines that secrete proteinase inhibitors in vitro Virchows Arch B Cell Pathol Incl Mol Pathol 57 157 165 10.1007/BF02899077 1:CAS:528: DyaL1MXkslGlsLc%3D 2570482
27. H Kataoka K Seguchi T Inoue M Koono 1993 Properties of alpha1-antitrypsin secreted by human adenocarcinoma cell lines FEBS Lett 328 291 295 10.1016/0014-5793(93)80946-R 1:CAS:528:DyaK3sXlsFOgsr4%3D 8348978 (Pubitemid 23238106)
28. D Keppler M Markert B Carnal J Berdoz J Bamat B Sordat 1996 Human colon carcinoma cells synthesize and secrete alpha1-proteinase inhibitor Biol Chem Hoppe Seyler 377 301 311 1:CAS:528:DyaK28XktFyju74%3D 8828821
29. S Tamir SS Kadner J Katz TH Finlay 1990 Regulation of antitrypsin and antichymotrypsin synthesis by MCF-7 breast cancer cell sublines Endocrinology 127 1319 1328 10.1210/endo-127-3-1319 1:CAS:528:DyaK3cXlsV2kur8%3D 2201535
30. R Sawaya M Zuccarello R Highsmith 1987 Alpha-1-antitrypsin in human brain tumors J Neurosurg 67 258 262 10.3171/jns.1987.67.2.0258 1:STN:280: DyaL2s3ltlersg%3D%3D 3496430
31. H Allgayer R Babic KU Grutzner,, et al. 1998 Tumor-associated proteases and inhibitors in gastric cancer: analysis of prognostic impact and individual risk protease patterns Clin Exp Metastasis 16 62 73 10.1023/A:1006564002679 1:STN:280:DyaK1c7mtFWrsw%3D%3D 9502078 (Pubitemid 28122556)
32. B Hamrita K Chahed M Trimeche,, et al. 2009 Proteomics-based identification of alpha1-antitrypsin and haptoglobin precursors as novel serum markers in infiltrating ductal breast carcinomas Clin Chim Acta 404 111 118 10.1016/j.cca.2009.03.033 1:CAS:528:DC%2BD1MXmtlKgt7Y%3D 19306859
33. J Johansson S Grondal J Sjovall H Jornvall T Curstedt 1992 Identification of hydrophobic fragments of alpha1-antitrypsin and C1 protease inhibitor in human bile, plasma and spleen FEBS Lett 299 146 148 10.1016/0014-5793(92)80234-8 1:CAS:528:DyaK38XksVegsbo%3D 1544487
34. MA Niemann AJ Narkates EJ Miller 1992 Isolation and serine protease inhibitory activity of the 44-residue, C-terminal fragment of alpha1-antitrypsin from human placenta Matrix 12 233 241 1:CAS:528:DyaK38XlsVGqtL4%3D 1406456
35. R Huber RW Carrell 1989 Implications of the three-dimensional structure of alpha1-antitrypsin for structure and function of serpins Biochemistry 28 8951 8966 10.1021/bi00449a001 1:CAS:528:DyaL1MXmtFSku7Y%3D 2690952 (Pubitemid 19283457)
36. RW Carrell PA Pemberton DR Boswell 1987 The serpins: evolution and adaptation in a family of protease inhibitors Cold Spring Harb Symp Quant Biol 52 527 535 1:CAS:528:DyaL1cXlsVGisrg%3D 3502621
37. MA Niemann JE Baggott EJ Miller 1997 Binding of SPAAT the 44-residue C-terminal peptide of alpha1-antitrypsin, to proteins of the extracellular matrix J Cell Biochem 66 346 357 10.1002/(SICI)1097-4644(19970901)66:3<346:: AID-JCB7>3.0.CO;2-P 1:CAS:528:DyaK2sXlt1SitLk%3D 9257191 (Pubitemid 27332868)
38. H Kataoka H Uchino T Iwamura M Seiki K Nabeshima M Koono 1999 Enhanced tumor growth and invasiveness in vivo by a carboxyl-terminal fragment of alpha1-proteinase inhibitor generated by matrix metalloproteinases: a possible modulatory role in natural killer cytotoxicity Am J Pathol 154 457 468 1:CAS:528:DyaK1MXjtVCqtrw%3D 10027404
39. L Cercek B Cercek 1992 Cancer-associated SCM-recognition, immunedefense suppression, and serine protease protection peptide. Part I. Isolation, amino acid sequence, homology, and origin Cancer Detect Prev 16 305 319 1:CAS:528:DyaK3sXksVKnsLs%3D 1473120
40. L Cercek B Cercek 1993 Cancer-associated SCM-recognition, immunedefense suppression, and serine protease protection peptide. Part III. CRISPP peptide protection of serine proteases against inhibition Cancer Detect Prev 17 447 454 1:CAS:528:DyaK2cXhtlWjtrg%3D 7691406
41. L Cercek B Cercek 1993 Cancer-associated SCM-recognition, immunedefense suppression, and serine protease protection peptide. Part II. Immunedefense suppressive effects of the CRISPPs peptide Cancer Detect Prev 17 433 445 1:CAS:528:DyaK2cXhtlags7k%3D 7691405
42. J Brittenden SD Heys J Ross O Eremin 1996 Natural killer cells and cancer Cancer 77 1226 1243 10.1002/(SICI)1097-0142(19960401)77:7<1226::AID- CNCR2>3.0.CO;2-G 1:STN:280:DyaK287pslCitA%3D%3D 8608497 (Pubitemid 26102319)
43. Z Sun P Yang 2004 Role of imbalance between neutrophil elastase and alpha1-antitrypsin in cancer development and progression Lancet Oncol 5 182 190 10.1016/S1470-2045(04)01414-7 1:CAS:528:DC%2BD2cXhslSktL4%3D 15003202 (Pubitemid 38262851)